Key Takeaways Tempus AI acquired Paige, expanding its proprietary dataset and establishing a digital pathology presence. Paige Predict analyzes H&E slides to predict 123 biomarkers and pathways across 16 cancer types for TEM. TEM's Paige Predict integrates results into clinical reports for faster physician insights. Investors are increasingly focused on the artificial intelligence (AI) in pathology market, which is expected to reach $1.15 billion by 2033, at a CAGR of 27.18% between 2025 and 2033 (per Grand ...